Is BCH-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BCH-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BCH-F (THB18.7) is trading above our estimate of fair value (THB15.41)
Significantly Below Fair Value: BCH-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BCH-F?
Key metric: As BCH-F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for BCH-F. This is calculated by dividing BCH-F's market cap by their current
earnings.
What is BCH-F's PE Ratio?
PE Ratio
27.4x
Earnings
฿1.48b
Market Cap
฿40.40b
BCH-F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: BCH-F is expensive based on its Price-To-Earnings Ratio (27.4x) compared to the TH Healthcare industry average (21.8x).
Price to Earnings Ratio vs Fair Ratio
What is BCH-F's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
BCH-F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
27.4x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BCH-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.